T-cell Infusion Targeting BCMA and CD19 for Refractory/Relapsed Systemic Lupus Erythematosus (SLE) Patients With or Without Organs Involvement
Latest Information Update: 18 Oct 2024
At a glance
- Drugs Chimeric antigen receptor T cell therapy Essen Biotech (Primary) ; Cyclophosphamide; Fludarabine
- Indications Systemic lupus erythematosus
- Focus Adverse reactions
- Sponsors Essen BioTech
- 18 Oct 2024 New trial record